Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Actavis'_generic_business_in_India
|
| gptkbp:awards |
gptkb:Frost_&_Sullivan_Award_2018
Pharma Leaders Award 2019 Best_Pharmaceutical_Company_Award_2020 |
| gptkbp:CEO |
gptkb:Bhavin_S._Mehta
|
| gptkbp:certifications |
gptkb:ISO_9001
gptkb:US_FDA gptkb:WHO_GMP |
| gptkbp:clinicalTrials |
Conducting clinical trials for new drugs.
Collaboration with global clinical research organizations. |
| gptkbp:employees |
Over 10,000
|
| gptkbp:expansion |
Manufacturing facilities in multiple countries
Research_centers_in_India_and_abroad |
| gptkbp:founded |
1984
|
| gptkbp:founder |
gptkb:Bhavin_S._Mehta
|
| gptkbp:global_presence |
Exporting to more than 85 countries.
Operations in over 70 countries. |
| gptkbp:headquarters |
Ahmedabad,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Intas Pharmaceuticals Ltd.
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Significant investment in R&D.
Investment in state-of-the-art manufacturing facilities. Investment in technology upgrades. |
| gptkbp:market |
Global
|
| gptkbp:mission |
To provide high-quality, affordable medicines.
|
| gptkbp:partnerships |
Various international pharmaceutical companies
Collaborations with research institutions. Joint ventures with other pharmaceutical companies. |
| gptkbp:priceRange |
Over 300 products.
Therapeutic segments covering various diseases. |
| gptkbp:products |
Biologics
Over-the-counter medications Generic_drugs |
| gptkbp:research_areas |
Cardiology
Gastroenterology Oncology Diabetes Neurology Infectious diseases Respiratory |
| gptkbp:researchAndDevelopment |
Focus on complex generics
Focus on biosimilars Focus on novel drug delivery systems |
| gptkbp:revenue |
Approximately $1 billion
|
| gptkbp:social_responsibility |
Community health programs
Environmental sustainability initiatives Employee welfare programs Education support programs Healthcare_initiatives |
| gptkbp:stockExchange |
Listed on BSE
Listed on NSE |
| gptkbp:subsidiary |
gptkb:Intas_Biopharmaceuticals_Ltd.
gptkb:Intas_Pharmaceuticals_Inc. |
| gptkbp:sustainability |
Focus on reducing carbon footprint.
Commitment to sustainable practices. Water conservation efforts. Waste management initiatives. Energy efficiency programs. |
| gptkbp:vision |
To be a global leader in the pharmaceutical industry.
|
| gptkbp:website |
www.intaspharma.com
|